Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
NCT06967389
Body Weight, Body Weight Changes
Lexington, Kentucky, United States
View Trial DetailsNCT Number: NCT06585371
Post-market observational, adaptive, single-arm clinical study to evaluate the percentage of total weight loss after treatment with an intragastric balloon. Patients will be followed for 6 months after the device is installed.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Forty-six overweight patients over 18 years of age with a BMI of 27 kg/m2 or greater who are considered suitable for intragastric balloon placement will be included. The primary outcome will be the assessment of the percentage of total weight loss (%WL) at 6 months. Patients will be screened in an outpatient setting at the participating research center. All participants who meet the eligibility criteria will be invited to participate in the study, which includes a screening visit, standard intragastric balloon placement procedure, and follow-up visits.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the installation of the balloon to the end of treatment at 6 months
To analyze the percentage of total weight loss 6 months after installation of the intragastric balloon, the following formula will be used:
Percentage of total weight loss = kilos lost/initial weight x 100
Time frame: From the installation of the balloon to the end of treatment at 6 months
Adverse event monitoring through medical clinical evaluation
Time frame: From the installation of the balloon to the end of treatment at 6 months
Patients will be weighed on an anthropometric balance during in-person consultations
Time frame: From the installation of the balloon to the end of treatment at 6 months
To analyze the BMI changes, the BMI will be calculated in the follow-up medical consultations by dividing the weight (in kg) by the square of the height (in meters), according to the following formula: BMI = weight/(height x height)
Time frame: From the installation of the balloon to the end of treatment at 6 months
To measure abdominal circumference, during in-person medical consultations, the patient will stand with arms extended at the side of the body, feet apart and parallel. The measuring tape will be positioned around the abdomen, midway between the lower costal margin and the iliac crest.
Contact information is provided by the study sponsor or research team.
MEDICONE PROJETOS E SOLUCOES PARA A INDUSTRIA E A SAUDE LTDA
Other
Evaluation of the Safety and Efficacy of a 6-month Intragastric Balloon
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06967389
Body Weight, Body Weight Changes
Lexington, Kentucky, United States
View Trial DetailsNCT06737042
Body Weight, Body Weight Changes
Bessemer, Alabama, United States
View Trial DetailsNCT06976307
Behavior, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT07674875
Behavior, Body Weight
Antalya, Konyaalti, Turkey (Türkiye)
View Trial Details